栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/11/20 | 2,433 | 2,481 | 2,426 | 2,458 | +15 | +0.6% | 111,500 |
2018/11/19 | 2,400 | 2,444 | 2,400 | 2,443 | +44 | +1.8% | 69,200 |
2018/11/16 | 2,423 | 2,436 | 2,357 | 2,399 | -24 | -1% | 104,400 |
2018/11/15 | 2,415 | 2,442 | 2,382 | 2,423 | -6 | -0.2% | 74,100 |
2018/11/14 | 2,454 | 2,501 | 2,402 | 2,429 | -12 | -0.5% | 105,400 |
2018/11/13 | 2,401 | 2,475 | 2,392 | 2,441 | -30 | -1.2% | 124,700 |
2018/11/12 | 2,499 | 2,529 | 2,456 | 2,471 | -58 | -2.3% | 77,000 |
2018/11/09 | 2,540 | 2,578 | 2,514 | 2,529 | -12 | -0.5% | 110,900 |
2018/11/08 | 2,508 | 2,549 | 2,466 | 2,541 | +48 | +1.9% | 134,500 |
2018/11/07 | 2,537 | 2,548 | 2,483 | 2,493 | -12 | -0.5% | 74,300 |
2018/11/06 | 2,479 | 2,526 | 2,450 | 2,505 | +50 | +2% | 75,000 |
2018/11/05 | 2,473 | 2,490 | 2,433 | 2,455 | -25 | -1% | 57,600 |
2018/11/02 | 2,500 | 2,514 | 2,420 | 2,480 | -28 | -1.1% | 110,500 |
2018/11/01 | 2,475 | 2,558 | 2,417 | 2,508 | -16 | -0.6% | 157,800 |
2018/10/31 | 2,419 | 2,535 | 2,391 | 2,524 | +124 | +5.2% | 176,400 |
2018/10/30 | 2,320 | 2,461 | 2,320 | 2,400 | +72 | +3.1% | 407,600 |
2018/10/29 | 2,368 | 2,403 | 2,316 | 2,328 | +3 | +0.1% | 322,600 |
2018/10/26 | 2,428 | 2,428 | 2,302 | 2,325 | -103 | -4.2% | 334,500 |
2018/10/25 | 2,257 | 2,485 | 2,252 | 2,428 | +155 | +6.8% | 544,900 |
2018/10/24 | 2,389 | 2,447 | 2,218 | 2,273 | -316 | -12.2% | 546,300 |
2018/10/23 | 2,600 | 2,648 | 2,571 | 2,589 | +27 | +1.1% | 292,000 |
2018/10/22 | 2,530 | 2,573 | 2,481 | 2,562 | +35 | +1.4% | 125,700 |
2018/10/19 | 2,505 | 2,537 | 2,466 | 2,527 | +15 | +0.6% | 167,100 |
2018/10/18 | 2,514 | 2,542 | 2,471 | 2,512 | +10 | +0.4% | 108,100 |
2018/10/17 | 2,434 | 2,507 | 2,409 | 2,502 | +97 | +4% | 106,900 |
2018/10/16 | 2,424 | 2,464 | 2,371 | 2,405 | -51 | -2.1% | 96,900 |
2018/10/15 | 2,400 | 2,480 | 2,400 | 2,456 | +50 | +2.1% | 124,000 |
2018/10/12 | 2,415 | 2,439 | 2,401 | 2,406 | -32 | -1.3% | 66,100 |
2018/10/11 | 2,443 | 2,482 | 2,421 | 2,438 | -72 | -2.9% | 139,600 |
2018/10/10 | 2,454 | 2,525 | 2,425 | 2,510 | +46 | +1.9% | 162,600 |
2018/10/09 | 2,469 | 2,523 | 2,447 | 2,464 | +8 | +0.3% | 192,000 |
2018/10/05 | 2,461 | 2,465 | 2,436 | 2,456 | -15 | -0.6% | 92,000 |
2018/10/04 | 2,504 | 2,520 | 2,469 | 2,471 | -63 | -2.5% | 140,500 |
2018/10/03 | 2,585 | 2,595 | 2,531 | 2,534 | -81 | -3.1% | 89,500 |
2018/10/02 | 2,677 | 2,678 | 2,597 | 2,615 | -32 | -1.2% | 112,300 |
2018/10/01 | 2,670 | 2,677 | 2,613 | 2,647 | +6 | +0.2% | 77,500 |
2018/09/28 | 2,659 | 2,668 | 2,619 | 2,641 | +5 | +0.2% | 91,000 |
2018/09/27 | 2,611 | 2,678 | 2,611 | 2,636 | -25 | -0.9% | 101,200 |
2018/09/26 | 2,587 | 2,662 | 2,582 | 2,661 | +56 | +2.1% | 96,900 |
2018/09/25 | 2,562 | 2,606 | 2,553 | 2,605 | +53 | +2.1% | 116,900 |
2018/09/21 | 2,553 | 2,573 | 2,539 | 2,552 | -5 | -0.2% | 93,400 |
2018/09/20 | 2,573 | 2,574 | 2,515 | 2,557 | +7 | +0.3% | 94,400 |
2018/09/19 | 2,522 | 2,555 | 2,496 | 2,550 | +65 | +2.6% | 127,700 |
2018/09/18 | 2,425 | 2,487 | 2,419 | 2,485 | +59 | +2.4% | 141,200 |
2018/09/14 | 2,433 | 2,433 | 2,388 | 2,426 | +20 | +0.8% | 106,300 |
2018/09/13 | 2,380 | 2,430 | 2,377 | 2,406 | +49 | +2.1% | 151,600 |
2018/09/12 | 2,367 | 2,367 | 2,290 | 2,357 | -14 | -0.6% | 172,600 |
2018/09/11 | 2,318 | 2,399 | 2,318 | 2,371 | +101 | +4.4% | 240,000 |
2018/09/10 | 2,268 | 2,296 | 2,267 | 2,270 | +2 | +0.1% | 36,600 |
2018/09/07 | 2,285 | 2,305 | 2,252 | 2,268 | -32 | -1.4% | 58,400 |
1451~
1500
件表示中 / 6826件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 232,200円 | +0.4% | -8.4% | 2.28% | 30.69倍 | 1.75倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 121,300円 | +197.7% | - | 0.00% | 49.57倍 | 1.58倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 151,800円 | +3.2% | +4.5% | 3.43% | 17.44倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
JCRファーマ | 67,900円 | -3.7% | -36.7% | 2.95% | 23.03倍 | 1.50倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
サンバイオ | 101,300円 | - | - | 0.00% | - | 51.01倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム